Business Context and Reporting Period
This Form 8-K was filed by Palisade Bio, Inc. on February 24, 2022. The report serves as a current disclosure pursuant to Regulation FD, announcing the release of a revised corporate presentation available on the company's website.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a disclosure of a corporate presentation rather than a financial statement.
Material Changes
The material event reported is the issuance of a revised corporate presentation. The filing explicitly states that the information contained in the presentation is "furnished" and not "filed" for purposes of Section 18 of the Exchange Act, nor is it incorporated by reference into other filings unless specifically stated by the Company.
Guidance, Outlook, and Risks
While the filing references a corporate presentation which typically contains outlook and risk information, the text of this 8-K does not summarize the specific guidance, management commentary, or risks contained within that presentation. Investors must refer to the attached Exhibit 99.1 for those details.
Investor Verification Checklist
- Verify the contents of the revised corporate presentation attached as Exhibit 99.1.
- Confirm that the presentation is not automatically incorporated by reference into other SEC filings.
- Review the company's website for the full text of the presentation referenced in Item 7.01.